BioArctic AB (OTCPK:BRCTF)
$ 15.76 -0.0368 (-0.23%) Market Cap: 1.37 Bil Enterprise Value: 1.32 Bil PE Ratio: 0 PB Ratio: 14.20 GF Score: 58/100

Q1 2019 BioArctic AB Earnings Call Transcript

May 09, 2019 / 07:30AM GMT
Operator

Hello, and welcome to the BioArctic Q1 2019 Report. (Operator Instructions) Just to remind you, this conference call is being recorded.

Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. Please go ahead with your meeting.

Gunilla Osswald;publ;CEO
BioArctic AB

()-

Thank you so much, and I'm happy to be here today and present the interim report from January to March 2019, and I will share the presentation with our CFO, Jan Mattsson.

Next slide, please. So BioArctic, here we are on the dot com -- NASDAQ.com exchange, and that -- this is our disclaimer. Next slide, please.

So today, I will start with a summary of our great projects -- progress in the projects for 2018 and for the beginning of this year. And I think we have had a great projects in all 3 disease areas as well as with our technology platform in the blood-brain bio market.

I will start with Alzheimer's disease, where BAN2401 with our -- is our most advanced program. Last summer, we presented positive result

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot